Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

34.85p
   
  • Change Today:
    -0.60p
  • 52 Week High: 65.00
  • 52 Week Low: 25.50
  • Currency: UK Pounds
  • Shares Issued: 301.45m
  • Volume: 408,913
  • Market Cap: £105.06m
  • RiskGrade: 479

Regenersis CFO tops up stake as results impress

Date: Tuesday 24 Sep 2013

LONDON (ShareCast) - Jog Dhody, the Chief Financial Officer of Regenersis, on Tuesday acquired 39,000 ordinary shares in the outsourcing partner on the same day it posted "a strong financial performance and good growth" for the year ended June 30th.

Dhody bought the shares a price of 255p per share, spending a total of £99,450. Following the acquisition, he has a beneficial interest of 355,285 shares, representing 0.7% of the company's issued share capital.

In the 12 months to the end of June, the company's revenue increased to £179.7m (2012: £139.9m), while headline operating profit increased to £9.5m (2012: £7.8m) and pre-tax profit of £5.67m (2012: £1.68m).

Net debt fell to £1.9m (FY 2012: £2.9m and HY 2013: £7.7m).

The group recommended a final dividend of 1.83p per ordinary share (2012: 1.1p per share), giving a total dividend for the year of 2.5p per ordinary share (2012: 1.1p) - up 127%.


Top Director Buys

Patagonia Gold (PGD)
Director name: Mr Carlos Miguens
Amount purchased: 7,608,090 @ 11.50p
Value: £874,930

HydroDec Group (HYR)
Director name: Mr Andrew Black
Amount purchased: 1,200,000 @ 12.88p
Value: £154,560

Regenersis (RGS)
Director name: Mr Jog Dhody
Amount purchased: 39,000 @ 255.00p
Value: £99,450

Partnership Assurance Group (PA.)
Director name: Mr Steve Groves
Amount purchased: 24,390 @ 407.30p
Value: £99,340

Patagonia Gold (PGD)
Director name: Mr Gonzalo Tanoira
Amount purchased: 842,580 @ 11.50p
Value: £96,897

Alba Mineral Resources (ALBA)
Director name: Mr Michael Nott
Amount purchased: 10,440,606 @ 0.30p
Value: £31,322

Fisher (James) & Sons (FSJ)
Director name: Mr Charles J Rice
Amount purchased: 1,753 @ 1,098.00p
Value: £19,248

GKN (GKN)
Director name: Mr William C Seeger
Amount purchased: 4,367 @ 358.60p
Value: £15,660


Top Director Sells

Diageo (DGE)
Director name: Mr Ivan Menezes
Amount sold: 93,544 @ 2,033.14p
Value: £1,901,880

Diageo (DGE)
Director name: Ms Deirdre Mahlan
Amount sold: 80,502 @ 2,062.00p
Value: £1,659,951

Jupiter Fund Management (JUP)
Director name: Mr Philip Johnson
Amount sold: 200,000 @ 377.16p
Value: £754,320

Park Group (PKG)
Director name: Mr Christopher Houghton
Amount sold: 567,461 @ 53.50p
Value: £303,592

Park Group (PKG)
Director name: Mr Gary Woods
Amount sold: 511,594 @ 53.50p
Value: £273,703

Park Group (PKG)
Director name: Mr Marti Stewart
Amount sold: 319,243 @ 53.50p
Value: £170,795

Jardine Matheson Holdings Ltd (Singapore Reg) (JAR)
Director name: Mr E P K Weatherall
Amount sold: 455 @ $66.37
Value: $30,198

Futura Medical (FUM)
Director name: Mr David Bryn Davies
Amount sold: 20,000 @ 70.00p
Value: £14,000

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 34.85p
Change Today -0.60p
% Change -1.69 %
52 Week High 65.00
52 Week Low 25.50
Volume 408,913
Shares Issued 301.45m
Market Cap £105.06m
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.16% below the market average47.16% below the market average47.16% below the market average47.16% below the market average47.16% below the market average
9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average9.8% below the sector average
Price Trend
2.18% above the market average2.18% above the market average2.18% above the market average2.18% above the market average2.18% above the market average
60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average60.71% above the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
16:35 9,297 @ 34.85p
16:35 3,064 @ 34.85p
16:35 1,233 @ 34.85p
16:35 703 @ 34.85p
16:35 2,913 @ 34.85p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page